(Q38199712)

30 August 2017

title

The development of new basal insulins: is there any clinical advantage with their use in type 2 diabetes? (English)

1 reference

30 August 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673155%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Michela Petrizzo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673155%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Annalisa Capuano

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673155%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Dario Giugliano

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673155%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Katherine Esposito

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673155%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

language of work or name

English

0 references

publication date

27 March 2014

1 reference

Expert Opinion on Biological Therapy

30 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673155%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673155%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673155%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

799-808

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673155%20AND%20SRC:MED&resulttype=core&format=json

The Past 200 Years in Diabetes

11 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

Rat Insulin Genes: Construction of Plasmids Containing the Coding Sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

Current insulin analogues in the treatment of diabetes: emphasis on type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

Humalog (lispro) for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

The physiologic replacement of insulin. An elusive goal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

Self-mixed/split insulin regimen: a serious omission in the ADA/EASD position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

Refining basal insulin therapy: what have we learned in the age of analogues?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

How hypoglycaemia can affect the life of a person with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

The impact of non-severe hypoglycemic events on work productivity and diabetes management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

Treatment regimens with insulin analogues and haemoglobin A1c target of <7% in type 2 diabetes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

Basal insulin analogues in the management of diabetes mellitus: What progress have we made?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

Insulin degludec compared with insulin glargine in insulin-naïve patients with type 2 diabetes: A 26-week, randomized, controlled, Pan-Asian, treat-to-target trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily: a 26-week, randomized, open-label, parallel-group, treat-to-target trial in i

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

Low-volume insulin degludec 200 units/ml once daily improves glycemic control similarly to insulin glargine with a low risk of hypoglycemia in insulin-naive patients with type 2 diabetes: a 26-week, randomized, controlled, multinational, treat-to-ta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

Efficacy and safety of insulin degludec three times a week versus insulin glargine once a day in insulin-naive patients with type 2 diabetes: results of two phase 3, 26 week, randomised, open-label, treat-to-target, non-inferiority trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

Insulin degludec is not associated with a delayed or diminished response to hypoglycaemia compared with insulin glargine in type 1 diabetes: a double-blind randomised crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

Novel PEGylated basal insulin LY2605541 has a preferential hepatic effect on glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

Better glycemic control and weight loss with the novel long-acting basal insulin LY2605541 compared with insulin glargine in type 1 diabetes: a randomized, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

Hyperglycemia slows embryonic growth and suppresses cell cycle via cyclin D1 and p21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

Basal supplementation of insulin lispro protamine suspension versus insulin glargine and detemir for type 2 diabetes: meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

Insulin degludec: a new insulin for today?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

LY2605541--A Preferential Hepato-Specific Insulin Analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.895812

10.1517/14712598.2014.895812

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673155%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference